Literatur
- 1
Pannen B HJ, Koehler N, Hole B, Bauer M, Clemens M G, Geiger K K.
Protective role of endogenous carbon monoxide in hepatic microcirculatory dysfunction
after hemorrhagic shock.
J Clin Invest.
1998;
102
1220-1228
- 2
Pannen B HJ, Schroll S, Loop T, Bauer M, Hoetzel A, Geiger K K.
Hemorrhagic shock primes the hepatic portal circulation for the vasoconstrictive effects
of endothelin-1.
Am J Physiol Heart Circ Physiol.
2001;
281
H1075-H1084
- 3
Pannen B HJ.
New insights into the regulation of hepatic blood flow after ischemia and reperfusion.
Anesth Analg.
2002;
94
1448-1457
- 4
Rivers E, Nguyen B, Havstad S, Ressler B S, Muzzin A, Knoblich B, Peterson E, Tomlanovich M.
Early goal-directed therapy in the treatment of severe sepsis and septic shock.
New Engl J Med.
2001;
345
1368-1377
- 5
Sakka S G, Reinhart K, Meier-Hellmann A.
Does optimization of cardiac output by fluid loading increase splanchnic blood flow?.
Br J Anaesth.
2001;
86
657-662
- 6
Hebert P C, Wells G, Blajchman M A, Marshall J, Martin C, Pagliarello G TMSI, Yetisir E,.
The Transfusion Requirements in Critical Care Investigators for the Canadian Critical
Care Trials Group .
A multicenter randomized controlled clinical trial of transfusion requirements in
critical care.
New Engl J Med.
1999;
340
409-417
- 7
Marik P E, Sibbald W J.
Effect of stored-blood transfusion on oxygen delivery in patients with sepsis.
JAMA.
1993;
269
3024-3029
- 8
Marik P E, Mohedin M.
The contrasting effects of dopamine and norepinephrine on systemic and splanchnic
oxygen utilization in hyperdynamic sepsis.
JAMA.
1994;
272
1354-1357
- 9
Reinelt H, Radermacher P, Kiefer P, Fischer G, Wachter U, Vogt J, Georgieff M.
Impact of exogenous beta-adrenergic receptor stimulation on hepatosplanchnic oxygen
kinetics and metabolic activity in septic shock.
Crit Care Med.
1999;
27
325-331
- 10
Joly L M, Monchi M, Cariou A, Chiche J D, Bellenfant F, Brunet F, Dhainaut J F.
Effects of dobutamine on gastric mucosal perfusion and hepatic metabolism in patients
with septic shock.
Am J Respir Crit Care Med.
1999;
160
1983-1986
- 11
Reinelt H, Radermacher P, Fischer G, Geisser W, Wachter U, Wiedeck H, Georgieff M,
Vogt J.
Effects of dobutamine-induced increase in splanchnic blood flow on hepatic metabolic
activity in patients with septic shock.
Anesthesiology.
1997;
86
818-824
- 12
Meier-Hellmann A, Reinhart K, Bredle D L, Specht M, Spies C D, Hannemann L.
Epinephrine impairs splanchnic perfusion in septic shock.
Crit Care Med.
1997;
25
399-404
- 13
Neviere R, Mathieu D, Chagnon J L, Lebleu N, Wattel F.
The contrasting effects of dobutamine and dopamine on gastric mucosal perfusion in
septic patients.
Am J Respir Crit Care Med.
1996;
154
1684-1688
- 14
Meier-Hellmann A, Bredle D L, Specht M, Spies C, Hannemann L, Reinhart K.
The effects of low-dose dopamine on splanchnic blood flow and oxygen uptake in patients
with septic shock.
Intensive Care Med.
1997;
23
31-37
- 15
Maynard N D, Bihari D J, Dalton R N, Smithies M N, Mason R C.
Increasing splanchnic blood flow in the critically ill.
Chest.
1995;
108
1648-1654
- 16
Meier-Hellmann A, Bredle D L, Specht M, Hannemann L, Reinhart K.
Dopexamine increases splanchnic blood flow but decreases gastric mucoal pH in severe
septic patients treated with dobutamine.
Crit Care Med.
1999;
27
2166-2171
- 17
Kiefer P, Tugtekin I, Wiedeck H, Bracht H, Geldner G, Georgieff M, Radermacher P.
Effect of a dopexamine-induced increase in cardiac index on splanchnic hemodynamics
in septic shock.
Am J Respir Crit Care Med.
2000;
161
775-779
- 18
Kiefer P, Tugtekin I, Wiedeck H, Bracht H, Vogt J, Wachter U, Weiss M, Altin C, Georgieff M,
Radermacher P.
Hepato-splanchnic metabolic effects of the stable prostacyclin analogue iloprost in
patients with septic shock.
Intensive Care Med.
2001;
27
1179-1186
- 19
Lehmann C, Taymoorian K, Wauer H, Krausch D, Birnbaum J, Kox W J.
Effects of the stable prostacyclin analogue iloprost on the plasma disappearance rate
of indocyanine green in human septic shock.
Intensive Care Med.
2000;
26
1557-1560
- 20
Pannen B HJ, Bauer M, Zhang J X, Robotham J L, Clemens M G.
A time-dependent balance between endothelins and nitric oxide regulating portal resistance
after endotoxin.
Am J Physiol.
1996;
271
H19 53- H19 61
- 21
Bakker J, Grover R, McLuckie A, Holzapfel L, Andersson J, Lodato R, Watson D, Grossman S,
Donaldson J, Takala J. on behalf of the Glaxo Wellcome International Septic Shock
Study Group .
Administration of the nitric oxide synthase inhibitor NG-methyl-L-arginine hydrochloride (546C88) by intravenous infusion for up to 72 hours
can promote the resolution of shock in patients with severe sepsis: Results of a randomized,
double-blind, placebo-controlled multicenter study (study no. 144 - 002).
Crit Care Med.
2004;
32
1-12
- 22
Lopez A, Lorente J A, Steingrub J, Bakker J, McLuckie A, Willats S, Brockway A, Anzueto A,
Holzapfel L, Breen D, Silverman S, Takala J, Donaldson J, Arneson C, Grove G, Grossman S,
Grover R.
Multiple-center, randomized, placebo-controlled, double-blind study of the nitric
oxide synthase inhibitor 546C88: Effect on survival in patients with septic shock.
Crit Care Med.
2004;
32
21-30
- 23
Klinzing S, Simon M, Reinhart K, Bredle D L, Meier-Hellmann A.
High-dose vasopressin is not superior to norepinephrine in septic shock.
Crit Care Med.
2003;
31
2646-2650
- 24
Spackmann D R, McLeod A DM, Prineas S N, Leach R M, Reynolds F.
Effect of epidural blockade on indicators of splanchnic perfusion and gut function
in critically ill patients with peritonitis: a randomised comparison of epidural bupivacain
with systemic morphine.
Intensive Care Med.
2000;
26
1638-1645
- 25
Kern H, Schröder T, Kaulfuss M, Martin M, Kox W J, Spies C.
Enoximone in contrast to dobutamine improves hepatosplanchnic function in fluid-optimized
septic shock patients.
Crit Care Med.
2001;
29
1519-1525
- 26
Rank N, Michel C, Haertel C, Lenhart A, Welte M, Meier-Hellmann A, Spies C.
N-Acetylcysteine increases liver blood flow and improves liver function in septic
shock patients: Results of a prospective, randomized, double-blind study.
Crit Care Med.
2000;
28
3799-3807
Univ.-Prof. Dr. med. Benedikt H. J. Pannen
Geschäftsführender Oberarzt, Anästhesiologische Universitätsklinik Freiburg
Hugstetter Straße 55 · 79106 Freiburg ·
Email: pannen@ana1.ukl.uni-freiburg.de